Changes in total cholesterol and other lipid measurements for both lurasidone doses ( 40 and 120 mg / day ) were similar to placebo ( median change : total cholesterol -8.0 mg / dL and -5.0 mg / dL vs. -5.0 mg / dL placebo ; and triglycerides -3.0 mg / dL and 4.5 mg / dL vs. -1.0 mg / dL placebo , respectively , at study endpoint ) .